focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 24.00
Ask: 25.00
Change: 1.25 (5.38%)
Spread: 1.00 (4.167%)
Open: 24.25
High: 24.50
Low: 22.75
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Angle CEO, finance chief join capital raise

Tue, 19th Jul 2022 16:35

(Sharecast News) - Liquid biopsy specialist Angle had two entries on the list of director buys on Tuesday, after its chief executive and chief financial officers invested in shares.

The AIM-traded firm said CEO Andrew Newland bought 125,000 shares for 80p each, spending a total of £100,000.

At the same time, its CFO Ian Griffiths spent £30,000 on 37,500 shares, also at 80p apiece.

Both transactions took place off-market, as part of the company's capital raise of £20.13m through a placing, retail offer and management subscription, announced on Friday.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Alphawave Ip Group (AWE)

Director name: Sutardja,Sehat

Amount purchased: 538,867 @ 121.84p

Value: £656,555.55

Angle (AGL)

Director name: Newland,Andrew D

Amount purchased: 125,000 @ 80.00p

Value: £100,000.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 10,000 @ 887.70p

Value: £88,770.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 10,000 @ 871.54p

Value: £87,154.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 4,000 @ 877.10p

Value: £35,084.00

Angle (AGL)

Director name: Griffiths,Ian F

Amount purchased: 37,500 @ 80.00p

Value: £30,000.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,816 @ 887.54p

Value: £24,993.13

Schroder British Opportunities Trust (SBO)

Director name: Bartlett,Diana Dyer

Amount purchased: 26,345 @ 75.50p

Value: £19,890.47

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,000 @ 960.00p

Value: £19,200.00

Fevertree Drinks (FEVR)

Director name: Havelock,Kevin

Amount purchased: 2,000 @ 956.58p

Value: £19,131.60

More Acquisitions (TMOR)

Director name: McIllree ,Roderick

Amount purchased: 2,000,000 @ 0.95p

Value: £18,900.00

Schroder British Opportunities Trust (SBO)

Director name: England,Neil

Amount purchased: 25,000 @ 75.15p

Value: £18,787.50

Audioboom Group (BOOM)

Director name: Last,Stuart

Amount purchased: 1,218 @ 820.00p

Value: £9,987.60

Audioboom Group (BOOM)

Director name: Last,Stuart

Amount purchased: 1,410 @ 708.25p

Value: £9,986.32

Audioboom Group (BOOM)

Director name: Tobin,Michael

Amount purchased: 1,117 @ 850.00p

Value: £9,494.50

Genflow Biosciences (GENF)

Director name: Leire,Eric

Amount purchased: 308,999 @ 3.03p

Value: £9,362.67

Velocys Plc (VLS)

Director name: Sanderson,Philip

Amount purchased: 200,000 @ 4.30p

Value: £8,600.00

Time Finance (TIME)

Director name: Roberts ,James

Amount purchased: 26,972 @ 18.50p

Value: £4,989.82

Schroder British Opportunities Trust (SBO)

Director name: Jenkinson,Tim

Amount purchased: 6,609 @ 75.15p

Value: £4,966.53

Schroder British Opportunities Trust (SBO)

Director name: OBE,Christopher Keljik,

Amount purchased: 6,577 @ 75.50p

Value: £4,965.50

Time Finance (TIME)

Director name: Telling,Julian

Amount purchased: 26,000 @ 18.85p

Value: £4,901.00

Coca-cola Hbc Ag (cdi) (CCH)

Director name: Bogdanovic,Zoran

Amount purchased: 218 @ 1,956.75p

Value: £4,265.71

Time Finance (TIME)

Director name: Raynes ,Tanya

Amount purchased: 21,156 @ 18.85p

Value: £3,987.91

Bae Systems (BA.)

Director name: Woodburn,Charles

Amount purchased: 19 @ 804.96p

Value: £152.94

Bae Systems (BA.)

Director name: Greve,Brad

Amount purchased: 19 @ 804.96p

Value: £152.94

(HWG)

Director name: Birch,Chris

Amount purchased: 107 @ 140.00p

Value: £149.80

(HWG)

Director name: Patmore,Katerina

Amount purchased: 107 @ 140.00p

Value: £149.80

(HWG)

Director name: Shillaw,Lynda

Amount purchased: 107 @ 140.00p

Value: £149.80

More News
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.